Clinic-based and Technology-Supported Sleep Intervention for Pediatric Epilepsy

ConditionEpilepsy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-9
SponsorNational Taiwan University Hospital

About this trial

Sleep problems are more common and more severe in children with epilepsy. The purpose of this study is to develop and evaluate the effect of a clinic-based and technology-supported sleep intervention for improving sleep and health in children with epilepsy and their parents.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children aged between 1.5 and 9 years with a confirmed diagnosis of epilepsy.

Parents with sufficient Chinese language skills to fully comprehend the trial and complete questionnaires.

Disqualifiers

Children who are bedridden.

Children with a documented sleep disorder, such as obstructive or central sleep apnea and sleep-related movement disorders

Children born with a congenital, genetic, or orthopedic abnormality that limit their activities of daily living or impair their physical activity.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Clinic-based and technology-supported sleep intervention

    Behavioral

    CATS sleep intervention: The in-person sleep education and consultation will consist of 3 face-to-face, one-on-one sessions held 3 months apart during the child's routine clinic visit.The digital component of the sleep intervention will extend in-person education by providing ongoing support. Participants will receive one digital session per week for four weeks after the baseline, 3-month, and 6-month clinic visits, totaling 12 sessions.

Treatment groups

150 Participants
are divided into 2 treatment groups
Group A: Experimental intervention groupExperimental treatment 1 intervention
Group B: Usual care groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Sleep Efficiency by Actigraphy

Actigraphy is an objective sleep measurement method that assesses physical motion through a small device worn on the non-dominant wrist. Children's sleep will be objectively assessed for 7 days using actigraphy at each assessment time point. Sleep efficiency, a key indicator of sleep quality, is calculated as total nighttime sleep divided by time in bed × 100%.

Time frame
At baseline and at 3, 6, and 12 months after randomization.

Secondary outcomes

1

Sleep Onset Latency

Sleep onset latency is defined as the duration (minutes) from bedtime to actigraphy-derived sleep onset.

Time frame
At baseline and at 3, 6, and 12 months after randomization.
2

Wake After Sleep Onset (WASO)

WASO is defined as the duration (minutes) scored as wake between sleep onset and final awakening.

Time frame
At baseline and at 3, 6, and 12 months after randomization.
3

Total Nighttime Sleep

Total nighttime sleep by actigraphy is defined as the total duration scored as sleep within the nocturnal rest interval.

Time frame
At baseline and at 3, 6, and 12 months after randomization.
4

Daily 24-hour Sleep Duration

Daily 24-hour sleep duration is defined as the total duration scored as sleep.

Time frame
At baseline and at 3, 6, and 12 months after randomization.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.